According to Persistence Market Research, the global diagnostic imaging devices market is expected to be valued at US$34.3 billion in 2026 and projected to reach US$46.9 billion by 2033, expanding at a CAGR of 4.6% between 2026 and 2033. The market is being boosted by rising imaging volumes, an aging population, increasing chronic disease burden, replacement of aging equipment, and growing adoption of artificial intelligence across imaging workflows.
AI is Redefining the Capabilities of Diagnostic Imaging Devices
Diagnostic imaging is entering a phase where the machine is no longer responsible only for producing an image. Artificial intelligence is now being incorporated into image acquisition, reconstruction, analysis, workflow management, and clinical decision support. This is mainly important as healthcare settings face growing imaging volumes and shortages of trained radiology professionals.
The level of this transition is visible through the U.S. Food and Drug Administration (FDA). The FDA maintains a dedicated database of AI-enabled medical devices authorized for marketing in the U.S., with multiple radiology devices receiving regulatory decisions during 2026. These include Philips Spectral CT Verida, GE HealthCare automated aortic stenosis software, Siemens AI-Rad Companion Brain MR, and other imaging-related technologies.
Photon-counting CT is Raising the Bar for Computed Tomography
Computed tomography is also moving toward more advanced detector technology. Photon-counting CT can capture energy information from individual X-ray photons, creating opportunities for improved spectral imaging and more detailed clinical information from a single scan. The technology is attracting attention because it can potentially support more efficient examinations while expanding the information available to physicians.
A major 2026 development came from GE HealthCare, which received FDA 510(k) clearance for its Photonova Spectra photon-counting CT system in March 2026. The platform uses Deep Silicon detector technology and provides eight-bin energy resolution through a one-scan workflow, demonstrating how CT manufacturers are competing through detector innovation as well as conventional image quality.
The Radiology Workforce Challenge is Creating Demand for Automation
The expansion of imaging is occurring while healthcare institutions are dealing with workforce pressures. More examinations mean more images to acquire, process, interpret, and communicate, thereby increasing the workload for radiographers and radiologists. This is creating high demand for technologies that can automate repetitive activities without removing clinicians from the decision-making process.
Philips is also using AI to address workforce and workflow pressures in diagnostic imaging. In June 2026, the company received FDA 510(k) clearance for Elevate Plus, an AI-supported enhancement for its EPIQ Elite and Affiniti ultrasound systems. The technology is designed to automate routine measurements and support more consistent image acquisition, helping clinicians complete examinations faster and reduce variability in high-volume imaging environments.
Imaging Technology is Evolving for Diverse Patient Needs
The future of diagnostic imaging is not only about large scanners or high-resolution images. Manufacturers are also developing systems for specific clinical environments and patient groups. Specialized imaging can be particularly valuable when conventional equipment is difficult to use because of patient size, mobility, clinical condition, or care setting.
This trend can be seen in the FDA clearance of specialized technologies across radiology. In 2026, regulatory decisions included neonatal imaging technologies, AI-enabled MRI applications, advanced CT systems, and specialized ultrasound solutions. Such developments demonstrate that the market is becoming segmented around specific clinical needs rather than relying on one-size-fits-all imaging platforms.
Nuclear Imaging is Connecting Diagnosis with Precision Treatment
Another important area of development is nuclear medicine, where imaging is connected with targeted therapies. The growth of theranostics is creating a close relationship between identifying disease through molecular imaging and delivering treatment to specific biological targets. This is relevant in oncology, where imaging can help identify patients who may benefit from targeted radiopharmaceutical therapies.
GE HealthCare highlighted this trend in June 2026 at the Society of Nuclear Medicine and Molecular Imaging annual meeting. The company presented AI-enabled imaging and workflow technologies designed to support the expansion of nuclear medicine and theranostics. The development reflects a broad shift toward precision diagnostics in which imaging can contribute to both disease characterization and treatment planning.
Connected Imaging is Changing the Role of the Radiology Department
Imaging equipment is also becoming more connected to the wide healthcare infrastructure. Cloud platforms, enterprise imaging systems, remote access, and digital workflow tools can allow images to move across hospitals and specialties more efficiently. This can support collaboration between radiologists and physicians while helping healthcare organizations manage imaging data across multiple facilities.
The shift toward connected imaging is also creating new opportunities for collaboration between technology companies and clinical institutions. In July 2026, Philips and the University of Washington announced a collaboration focused on advanced MRI research and AI, including exploration of non-contrast breast imaging. The initiative demonstrates how imaging manufacturers are combining clinical expertise, research capabilities, and artificial intelligence to develop new approaches to diagnostic imaging.
Aging Equipment is Creating a Replacement Opportunity
Technology innovation is only one side of market growth. Healthcare providers also need to replace older imaging systems as equipment reaches the end of its operational life. Aging systems can create high maintenance requirements, workflow inefficiencies, and limitations in image quality or software compatibility. This replacement cycle is creating a steady opportunity for manufacturers as hospitals increasingly evaluate systems based on image quality, automation, connectivity, and long-term upgradeability rather than hardware specifications alone.
This creates an opportunity for manufacturers to compete not only on new technology but also on upgrade pathways. Hospitals can modernize existing imaging infrastructure through software, AI capabilities, detector improvements, and workflow upgrades rather than replacing every component at once. This approach can help healthcare providers balance technology investment with operational and budget constraints.
The Competitive Landscape is Shifting Toward Intelligent Imaging
The diagnostic imaging market is becoming very competitive as established manufacturers and specialized technology companies develop AI-enabled solutions. According to the 2026 AI Index, GE HealthCare, Siemens Healthineers, Philips, Canon Medical Systems, and Shanghai United Imaging Healthcare are among companies with substantial numbers of FDA-authorized AI-enabled medical devices. This indicates that AI is becoming an important competitive dimension within medical imaging rather than a niche technology.
The competition is also expanding beyond hardware. Companies are now differentiating through reconstruction software, AI algorithms, cloud connectivity, workflow automation, and specialized applications. This shift could gradually change how imaging devices are purchased, with healthcare providers evaluating the broad technology network rather than focusing only on scanner specifications.
Diagnostic Imaging is Entering an Intelligent Era
The diagnostic imaging devices market is moving toward a model where scanners, software, artificial intelligence, and connected healthcare systems work together. Developments in photon-counting CT, AI-enabled MRI and ultrasound, autonomous imaging research, specialized systems, and nuclear medicine are expanding the role of imaging across the patient journey.
The most important change is that diagnostic imaging is becoming more than a tool for producing pictures. It is becoming an intelligent part of diagnosis, clinical workflow, and precision medicine, creating new opportunities for equipment manufacturers, software providers, and healthcare systems. As healthcare providers face rising imaging demand and workforce constraints, the next phase of market growth will likely depend on how effectively manufacturers can combine better images, fast workflows, intelligent automation, and connected care into solutions that deliver measurable clinical value.
